Perspectives on Model‐Informed Precision Dosing in the Digital Health Era : Challenges, Opportunities, and Recommendations
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:109 |
|---|---|
| Enthalten in: |
Clinical Pharmacology & Therapeutics - 109(2021), 1, Seite 29-36 |
| Beteiligte Personen: |
Kluwe, Franziska [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2020 American Society for Clinical Pharmacology and Therapeutics |
|---|
| Umfang: |
8 |
|---|
| doi: |
10.1002/cpt.2049 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY004001850 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY004001850 | ||
| 003 | DE-627 | ||
| 005 | 20230307133020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230214s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/cpt.2049 |2 doi | |
| 028 | 5 | 2 | |a CPT_CPT2049.xml |
| 035 | |a (DE-627)WLY004001850 | ||
| 035 | |a (WILEY)CPT2049 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Kluwe, Franziska |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Perspectives on Model‐Informed Precision Dosing in the Digital Health Era |b Challenges, Opportunities, and Recommendations |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2020 American Society for Clinical Pharmacology and Therapeutics | ||
| 700 | 1 | |a Michelet, Robin |4 aut | |
| 700 | 1 | |a Mueller‐Schoell, Anna |4 aut | |
| 700 | 1 | |a Maier, Corinna |4 aut | |
| 700 | 1 | |a Klopp‐Schulze, Lena |4 aut | |
| 700 | 1 | |a Dyk, Madelé |4 aut | |
| 700 | 1 | |a Mikus, Gerd |4 aut | |
| 700 | 1 | |a Huisinga, Wilhelm |4 aut | |
| 700 | 1 | |a Kloft, Charlotte |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical Pharmacology & Therapeutics |g 109(2021), 1, Seite 29-36 |w (DE-627)WLY003995666 |x 15326535 |7 nnns |
| 773 | 1 | 8 | |g volume:109 |g year:2021 |g number:1 |g pages:29-36 |g extent:8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.38 |q ASE |
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 109 |j 2021 |e 1 |h 29-36 |g 8 | ||